Skip to main content
Signal8

Full Access with Signal8 Pro, $49/mo billed annually.

Court Unseals Key Evidence in Coventry Filing Showing Abacus Global Management Relied on Short Lapetus Life Expectancy Estimates and Misled Investors

$ABXPress releaseAug 4, 2026, 9:54 AM ETRead the release

Newly unsealed court documents in the litigation between Coventry First and Abacus Global Management (ABX) allege that ABX relied on inaccurate life expectancy estimates from Lapetus Solutions with an Actual-to-Expected ratio of just 41.5%. The filings claim ABX misled investors regarding a Lewis & Ellis valuation report by manipulating discount rates and withholding longer life expectancy estimates, inflating policy valuations by millions of dollars.

Key figures

Ae ratio
41.5%
Credit union investments
$500 million

AI analysis

Red flags3 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.